Cobicistat

Published October 15, 2012
Susa Coffey, MD
http://hivinsite.ucsf.edu/InSite?page=ar-06-02
Selected Reference
7. Kakuda TN, Opsomer M, Timmers M, et al. Bioavailability of two FDC formulations of darunavir/cobicistat 800/150 mg compared with darunavir/ritonavir 800/100 mg coadministered as single agents. In: Program and abstracts of the 13th International Workshop on Clinical Pharmacology of HIV Therapy; April 16-18, 2012; Barcelona. Abstract O_20.